 |
|
 |
| >Metabolic Institute of America |
 The Metabolic Institute of America was founded as an answer to the growing global epidemic of obesity and multiple metabolic disorders. It is dedicated to the clinical research and education of diabetes, hypertension, lipid disorders, obesity and related metabolic disorders in order to prevent cardiovascular disease and other associated complications. MIA’s mission is to advance the understanding and management of metabolic diseases.
Read about the institute staff |
| |
 |
|
 |
 |
The Metabolic Institute of America is inviting patients to participate in a clinical research study related to the Endocrine and Metabolic fields and focus on treatments for Diabetes Mellitis, Cholesterol & Lipid abnormalities and High blood pressure. Participating in a study will allow you to control a medical condition better while becoming an important part of medical science and its development.
To Participate in a Clinical Study Click Here |
 |
 |
 |
 | |
| |
|
|
|
|
 Yehuda Handelsman MD, FADP, FACE, is the Medical Director of the Metabolic Institute of America. He is an endocrinologist in solo private practice in Tarzana, California, where he developed and successfully utilizes a unique, multiple intervention approach to preventing cardiovascular disease in the high risk patient.
Read More about Yehuda Handelsman |
|
|
|
| |
|
|
|
|
The Medical Education Management (MEM) division is creating education initiatives and assists in the development of programs by others. It provides administrative services to national and international medical conferences and associations and interacts with the health media and lay associations to develop educational health programs for the public.
Read More
|
|
|
|
| | |
| |
|
|
|
|
Developing state of the art technique. Providing superior medical evaluation and treatment for patients with medical conditions. Predicting and Preventing Cardiovascular and Diabetes in person with Obesity, HTM, Lipid Disorders, Insulin Resistance and its complications like PCOS and Fatty Liver Disease.
|
|
|
|
| |
| |
| | |
| |
| | | | |
|
| |
| |
| |
|
